The core activity of Terapet SA is the development and manufacturing of innovative imaging and quality control technologies for nuclear medicine, proton therapy and precision medicine. In particular, the company focuses on the development of integrated imaging and quality control solutions for cancer treatment. The company's products, such as Qualyscan and Nuclyscan, aim to improve the quality and accuracy of nuclear medicine imaging procedures and proton therapies.